Analyst Activity – Leerink Swann Reiterates Outperform on SLDB – Solid Biosciences (NASDAQ:SLDB)

Analyst Ratings For SLDB – Solid Biosciences (NASDAQ:SLDB)

Story continues below

Today, Leerink Swann reiterated its Outperform rating on SLDB – Solid Biosciences (NASDAQ:SLDB) with a price target of $14.00.

Some recent analyst ratings include

  • 4/2/2018-Leerink Swann Reiterated Rating of Outperform .
  • 3/15/2018-JPMorgan Chase was Downgraded by analysts at JPMorgan Chase from a “Neutral ” rating to a ” Underweight” rating. They now have a $28.00 price target on the stock.
  • 2/21/2018-Chardan Capital initiated coverage with a Buy rating.
  • 2/20/2018-Instinet initiated coverage with a Buy rating.
  • 2/20/2018-Goldman Sachs initiated coverage with a Neutral rating.


    Recent Trading Activity for SLDB – Solid Biosciences (NASDAQ:SLDB)
    Shares of SLDB – Solid Biosciences closed the previous trading session at with 6.841000080108643 shares trading hands.

    An ad to help with our costs